Lufax Investors Urged to Act Ahead of Class Action Deadline on May 20, 2026

Addressing the Lufax Securities Class Action

Lufax Holding Ltd., a prominent player in the financial technology sector, is currently facing scrutiny amid allegations of securities fraud brought forth by Faruqi & Faruqi, LLP, a respected national securities law firm. Investors are advised to be vigilant as the class action deadline approaches on May 20, 2026.

Understanding the Allegations

The legal complaint asserts that Lufax and its executives made several misleading statements, exposing a disconcerting lack of internal controls. More specifically, claims include:
1. Misrepresentation of Financial Health: There are allegations that Lufax materially misstated its financial results, leading investors to believe the firm was on solid footing.
2. Failure to Disclose: The executives failed to reveal significant issues regarding the company's operations, misleading investors about Lufax's overall stability and growth potential.
3. Consequential Losses: As the true nature of the company’s struggles became public knowledge, investors reportedly incurred financial losses, a situation exacerbated by a plunge in Lufax’s stock price following a January 2025 disclosure about the potential removal of its auditors.

Lufax's Disclosures and Investor Reaction

On January 27, 2025, Lufax disclosed concerning news in a report to the U.S. Securities and Exchange Commission (SEC). This included information that its board had proposed to dismiss its auditors and warned of potential delays in announcing its 2024 annual report. Following this revelation, Lufax's American Depositary Share (ADS) price experienced a sharp decline, dropping 13.8%, closing at $2.49 per share that day.

The Role of Lead Plaintiffs

In a securities class action, a lead plaintiff is typically appointed to represent the class of investors who have been financially harmed. The lead plaintiff is chosen based on their ability to represent the interests of the class and their financial stake in the outcome of the case. If you purchased securities in Lufax between April 7, 2023, and January 26, 2025, you may qualify to be a lead plaintiff. Individuals interested in representing the class or those who prefer to remain passive should consider their options carefully. Importantly, opting out of becoming a lead plaintiff will not impact eligibility for any potential recovery.

Next Steps for Investors

Investors potentially affected by the allegations against Lufax should take prompt action. Faruqi & Faruqi is inviting those who suffered losses during the specified period to reach out directly for guidance on the next steps. Interested parties can contact James (Josh) Wilson, a partner at the firm, at 877-247-4292 or through their website.

Faruqi & Faruqi has built a reputation for advocating effectively for investor rights, successfully recovering hundreds of millions of dollars since its establishment in 1995. The firm emphasizes that all communications will remain confidential, and it encourages whistleblowers and former employees of Lufax to provide insights that could be beneficial to the case.

Conclusion

As the clock ticks towards the May 20, 2026 deadline, the time for Lufax investors to act is now. Whether you are considering stepping forward as a lead plaintiff or simply seeking more information on your legal rights, proactive engagement is essential during this pivotal phase. Keep abreast of developments in this case and consult with legal experts to navigate your options effectively.

Follow updates from Faruqi & Faruqi on platforms such as LinkedIn and other social media to stay informed on the latest regarding the Lufax class action.